Precision oncology operations for complex Phase I–III studies — CAR-T therapies, immunotherapy, targeted agents, and compassionate use programmes, managed with rigorous safety oversight.
Initiate an Oncology TrialMayomi Research Solutions supports oncology clinical trials spanning solid tumours, haematological malignancies, and immuno-oncology. Our team is experienced in managing the operational complexity of oncology studies — from adaptive Phase I dose-escalation designs to Phase III registration trials with multi-site coordination and centralised safety oversight.
We provide specialist support for RECIST 1.1 tumour assessments, immune-related adverse event management, checkpoint inhibitor protocols, and CAR-T cell therapy logistics including apheresis scheduling and infusion coordination.
Specialized capabilities built for the unique demands of oncology clinical research.
Operational expertise in CAR-T cell therapy logistics — apheresis scheduling, vein-to-vein timelines, manufacturing coordination, and cytokine release syndrome monitoring.
Centralised coordination of RECIST 1.1 tumour measurement workflows including imaging scheduling, radiologist liaison, electronic measurement verification, and progression event adjudication.
End-to-end management of compassionate use and named-patient programme applications including CDSCO submissions, ethics approval, and ongoing safety reporting.
Discuss your oncology trial design, patient population, and site requirements with our specialist clinical operations team.
Contact Our Team